Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4586014 | 0.92 | TSHR (0.35) | TSHRPLA2G4AMAPTHSD17B10POLB | |
| SCHEMBL4587492 | 0.89 | TSHR (0.35) | TSHRMAPTHSD17B10POLBFOLH1 | |
| SCHEMBL4588460 | 0.87 | TSHR (0.33) | TSHRPOLBFOLH1ALDH1A1 | |
| SCHEMBL4588061 | 0.87 | TSHR (0.32) | TSHRPLA2G4APOLB | |
| SCHEMBL4586945 | 0.83 | TSHR (0.32) | TSHRPOLBFOLH1ALDH1A1 | |
| SCHEMBL4589203 | 0.83 | TSHR (0.33) | TSHRPOLBFOLH1ALDH1A1 | |
| SCHEMBL4586518 | 0.83 | TSHR (0.32) | TSHRPOLB | |
| SCHEMBL4587490 | 0.83 | TSHR (0.32) | TSHRPOLB | |
| SCHEMBL4588478 | 0.82 | TSHR (0.32) | TSHRPOLBFOLH1ALDH1A1 | |
| SCHEMBL4587564 | 0.82 | TSHR (0.31) | TSHRPOLBFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-20 | — | — | US | claimed |
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | PC, PDK1, NOS3 | TSHR 1905/4885PLA2G4A 2235/4885MAPT 3734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.